Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
One-year efficacy of adjunctive use of Ripasudil, a rho-kinase inhibitor, in patients with glaucoma inadequately controlled with maximum medical therapy
PaperCitations, authors & open-access status
One-year efficacy of adjunctive use of Ripasudil, a rho-kinase inhibitor, in patients with glaucoma inadequately controlled with maximum medical therapy is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 31 citations, 2017 year and closed oa status.
31
Citations
2017
Year
closed
OA Status